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Abstract: 
Apolipoprotein (apo) E4, one of the three common isoforms of apoE, has been 
implicated in Alzheimer's disease (AD). The mechanism whereby apoE4 leads to the 
pathogenesis of AD is unknown. In the present study, I examined the effects of apoE on 
neurite outgrowth from adult mice cortical neurons (AMC) in culture. I found that 
neurite outgrowth from AMC neurons derived from apoE deficient/apoE gene knockout 
(apoE KO) mice is significantly shorter than that from age-, sex-, and strain-matched 
wild-type control mice. Furthermore, I present evidence for the differential effects of two 
isoforms of human apoE, apoE3 and apoE4, on neurite outgrowth from apoE KO 
neurons. Human apoE3 enhances neurite outgrowth whereas human apoE4 inhibits 
outgrowth. The differential effects of apoE3 and apoE4 on neurite outgrowth appear to 
be mediated by the low-density lipoprotein receptor related protein (LRP). Blocking of 
the LRP pathway of lipoprotein uptake with lactoferrin and receptor associated protein 
(RAP) abolished the differential effects of apoE isoforms on neurite outgrowth. Further 
understanding of the isoform specific cell biological processes mediated by apoE-LRP 
interactions in AMC culture may provide insight into AD pathogenesis. 
1 
Introduction: 
Apolipoprotein E (apoE) is a 299 amino acid protein (MW=34,200) encoded by a 
single gene located on chromosome 19 in human (Rall et al., 1982; Das et al., 1985; Paik 
et al., 1985). The gene is highly polymorphic. In human, among all the variants, there 
are three major isoforms of apoE, apoE2, apoE3, and apoE4 that are produced by three 
alleles ( e2, e3, and e4). The frequencies of these three alleles in the general population 
are 8%, 77%, and 15%, respectively (Mahley, 1988; Gooch and Stennett, 1996). The 
most common isoform, apoE3, has cysteine and arginine at positions 112 and 158. Both 
positions contain cysteine in apoE2, and arginine in apoE4 (Rall et al., 1982; Weisgraber, 
1994; Mahley et al., 1995). Mice have one form of apoE which resembles human apoE4 
by having arginine at both positions 112 and 158, but differs significantly in amino acid 
sequence at the carboxyl terminus (Weisgraber, 1994). 
ApoE functions in the redistribution of lipids among various tissues by interacting 
with lipoprotein receptors on target cells, and thus apoE plays a critical role in lipid 
metabolism. In the liver, the uptake of chylomicron remnants via low density lipoprotein 
(LDL) receptor-related protein (LRP) has been known to be mediated by apoE (Kowal et 
al., 1989, 1990). The clearance of very low-density lipoproteins (VLDL) and 
intermediate density lipoprotein (IDL) by the liver is also mediated by apoE through the 
LDL receptor. ApoE has also been suggested to play a role in the process of converting 
IDL to LDL by hepatic lipase. After LDL particles are produced, they are cleared by the 
liver via apoB 100 through the LDL receptor (Bradley et al. 1984; Weisgraber, 1994). In 
addition, the excessive cholesterol and other lipids in some cells may form complexes 
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with high density lipoprotein (HDL) containing apoE that can transport the HDL to other 
cells or to the liver for clearance (Weisgraber, 1994; Mahley et al., 1995). 
In humans the brain is second only to the liver in apoE production (Elshourbagy et al., 
1985; Beffert et al., 1998). In the central nervous system (CNS), apoE is synthesized and 
secreted primarily by astrocytes, and to a lesser extent, by macrophages (Elshourbagy et 
al., 1985; Pitas et al., 1987a). Within the cerebrospinal fluid, apoE is found associated 
with high density lipoprotein (HDL)-size lipoprotein particles and appear to play a major 
role in lipid transport in the CNS (Pitas et al., 1987b; Mahley et al., 1995; Beffert et al., 
1998). ApoE-containing lipoproteins bind to several lipoprotein receptors in the CNS, 
including the LDL receptor, the LDL receptor-related protein (LRP), the VLDL receptor, 
the glycoprotein (gp) 330, and apolipoprotein E receptor 2 (apoER2) (Herz et al., 1988; 
Kowal et al., 1990; Takahashi et al., 1992; Willnow et al., 1992; Beffert et al., 1998). 
These receptors are members of a single family of proteins that share structural and 
functional similarities. The LDL receptor and LRP are expressed by neurons (Pitas et al., 
1987b). Previous studies have shown that apoE plays a pivotal role in maintaining 
central nervous system function and synaptic plasticity, especially after neuronal damage. 
ApoE levels dramatically increase after brain damage. For example, the expression of 
apoE increases following optic nerve injury in rats (Ignatius et al., 1986). Furthermore, 
results from our laboratory have shown that apoE secretion increases 2-fold following 
olfactory nerve lesion in mice. It has also been shown that apoE mRNA expression in 
astrocytes in the hippocampus increases after entorhinal cortex lesion (Poirier et al., 
1991). ApoE appears to participate both in the scavenging oflipids generated after axon 
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degeneration and in lipid redistribution to sprouting neurites and to Schwann cells 
(Ignatius et al., 1987; Mahley et al., 1995). 
Numerous recent studies have demonstrated that inheritance of the e4 allele of apoE 
increases the risk of Alzheimer's disease (AD) and that the inheritance of the e2 allele 
decreases the risk. Alzheimer's disease is the major form of dementia, and is 
characterized by senile plaques and neurofibrillary tangles in the brain and loss of 
cholinergic neurons in the basal forebrain (Gooch and Stennett, 1996). The senile 
plaques in the brains of AD patients consist of amyloid deposits surrounded by 
dystrophic axons. The amyloid is referred to as f3-amyloid (Af3), which is a product of 
inappropriate cleavage from the amyloid precursor protein (APP) (Haass and Selkoe, 
1993; Gooch and Stennett, 1996; Vassar et al., 1999). The second major type of brain 
lesion in AD patients, the neurofibrillary tangles, are located in cell bodies and apical 
dendrites. The tangles contain paired helical filaments composed of abnormally 
phosphorylated tau proteins. Tau is one of the microtubule-associated proteins (MAPs) 
that stabilizes microtubules against disassembly and provides a mechanism for them to 
interact with other cell components (Gooch and Stennett, 1996). 
There are three forms of AD: early-onset familial AD, late-onset familial AD and 
sporadic AD. Early-onset familial AD, which accounts for only 5% of human patients, 
has been found to be related to mutations on chromosomes 1, 14, and 21 (Gooch and 
Stennett, 1996). The late-onset familial AD and sporadic AD, which accounts for 
approximately 95% of all late-onset AD cases, are associated with the inheritance of e4 
(Poirier et al., 1993; Beffert et al., 1998). About 80% of familial and 64% of sporadic 
late-onset AD cases carry at least one copy of the e4 allele compared to 31 % of controls 
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(Corder et al., 1993; Beffert et al., 1998). Furthermore, the e4 allele also has a strong 
impact on the age of onset of clinical symptoms in AD. Studies have shown that the 
average age at onset of AD patients without e4 allele is 84.3 years, compared to 75.5 
years with individuals with a single e4 allele, and 68.4 years in individuals with two 
copies of e4. Most importantly, the survival time also decreases with an increasing gene 
dose of apoE4 (Corder et al., 1993, Gooch and Stennett, 1996). These studies have been 
confirmed by many laboratories worldwide, and is now universally accepted that the 
apoE genotype is the major risk factor for AD. Unfortunately the mechanism whereby 
apoE4 leads to the pathogenesis of AD is unknown. 
Previous findings from our laboratory have shown that apoE isoforms differentially 
alter neurite outgrowth from both CNS and PNS neurons. In the presence of a source of 
lipid, purified human apoE3 increased neurite extension, whereas human apoE4 
decreased extension from cultured dorsal root ganglion neurons (DRG) (Nathan et al., 
1994). Similar results were observed in murine neuroblastoma cells (Neuro-2a) derived 
from the CNS (Bellosta et al., 1995; Nathan et al., 1995). These studies demonstrated 
that the effects of apoE isoforms on neurite outgrowth required the interaction of apoE 
with lipoprotein receptors. In DRG culture, the apoE isoform-specific effect on neurite 
outgrowth was abolished by addition of an antibody, 1D7, and also by reductive 
methylation of critical lysine residues in apoE (Nathan et al., 1994), both of these 
approaches inhibit apoE binding to lipoprotein receptors. Furthermore, in both DRG 
culture and Neuro-2a culture, a lipid source was required to initiate the apoE effects. 
Addition of free apoE3 or apoE4 without a lipid source had no effect on neurite 
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outgrowth (Nathan et al., 1994; Nathan et al., 1995) suggesting that the effects of apoE 
on neurite outgrowth are lipoprotein receptor-mediated. 
Among all the receptors known to bind apoE containing lipoproteins, two receptors: 
the LDL receptor, and the heparan sulfate proteoglycan (HSPG)-LRP have been very 
well studied (Herz et al., 1988; Kowal et al., 1990; Takahashi et al., 1992). In studies on 
the role of apoE on chylomicron remnant clearance, evidence has shown that although the 
LDL receptor may participate in the uptake of chylomicron remnants, it is not essential 
for the rapid clearance of the remnants (Ji et al., 1993). In contrast, previous studies have 
indicated that LRP is involved in the clearance of apoE-enriched remnants (Kowal et al., 
1990; Ji et al. 1993). Ji et al. (1993) demonstrated that the LRP and the cell-surface 
HSPG are jointly involved in the binding and internalization of apoE containing 
lipoproteins. Cultured CHO cells treated with heparinase demonstrated a remarkable 
decrease on the uptake of fluorescently labeled P-VLDL+apoE (Ji et al. 1993; Mahley et 
al., 1994). Lactoferrin, a 76-kD glycoprotein which contains a cluster of four arginine 
residues resembling the receptor-binding domain of apoE (Metz-Boutigue et al., 1984), 
bind to HSPG and LRP, and inhibit the plasma clearance of chylomicron remnants (Ji 
and Mahley, 1994). These results suggest that lipoproteins bind to HSPG prior to 
internalization by the LRP (Ji et al. 1993; Ji and Mahley, 1994). Previous studies have 
shown that receptor-associated protein (RAP, also called 39-kDa protein), which co-
purifies with LRP also inhibits the binding of apoE containing lipoproteins to LRP 
(Williams et al., 1992; Battey et al., 1994). 
How apoE isoforms differentially alter neurite outgrowth remains unclear, as is the 
relevance of these findings to adult neurons and Alzheimer's disease. The primary aim 
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of this study is to answer the second question by thoroughly examining the effects of 
apoE isoforms on neurite outgrowth from cortical neurons derived from the brains of 
adult mice. In this thesis, I demonstrate that (1) AMC neurons derived from apoE-
deficient mice (apoE K.O.) have significantly shorter neurite outgrowth than neurons 
derived from normal mice; (2) human apoE3 enhances and human apoE4 inhibits neurite 
outgrowth in AMC neurons derived from apoE KO. mice; and (3) the differential effects 
of apoE isoforms on neurite outgrowth in AMC neurons appears to require the LRP. 
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Methods and Materials 
Materials: 
AMC culture: Homozygous apoE KO mice (C57BL/6J-Apoe <tmiUnc» Cat. # 002052) and 
control mice (C57BL/6J, Cat. # 000664) were obtained from Jackson Laboratory (Bar 
Harbor, MA). Cell culture medium, including HibernateA (Cat. # 10740-025) and 
Neurobasal (Cat. # 21103-049), B27 medium supplement (Cat. # 17504-010) were 
purchased from Life Technologies Inc. (Gaithersburg, MD). Glutamine (Cat. # G-3126) 
and poly-D-lysine (Cat. # P-6407) were purchased from Sigma Chemicals (St. Louis, 
MO). Papain (Cat. # 3119) was obtained form Worthington (Lakewood, NJ). 
Gentamicin (Cat. # 15710-015), FGF2 (Cat. # 13256-029), and optiprep (Cat. # 103-
0061) were purchased from Life Technologies Inc. (Gaithersburg, MD). Twelve mm 
glass coverslips (Cat. # P7-63-3029) were purchased from Carolina Biological 
(Burlington, NC). Falcon Brand 35 mm diameter dish (Cat. # 08-772-4A), Costar Brand 
Tissue Culture 24-well plates (Cat. # 07-200-84), 50 ml centrifuge tube (Cat. # 05-539-
6), 15 ml centrifuge tube (Cat.# 05-539-5), and 9-inch Pasteur pipette (Cat. # 13-678-6B) 
were purchased from Fisher Scientific (Chicago, IL). 
Neurite Outgrowth Assay: Human recombinant apoE3 (Cat. # P2003) and apoE4 (Cat. # 
P2004) were purchased from Panvera (Madison, WI). Lactoferrin (Cat. # L-4756) was 
obtained from Sigma Chemical (St. Louis, MO). Purified RAP was generously provided 
by Dr. Dudley Strickland (American Red Cross, Rockville, MD). 
ApoE Quantification: The mouse anti-human apoE (Cat. # MAB 1062) used for 
immunoprecipitation, was purchased from Chemicon (Temecula, TA). Protein A-
sepharose CL-4B (Cat. # P-3391) and BSA (Cat. # A-9418) were obtained from Sigma 
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Chemicals (St. Louis, MO). Goat anti-human apoE (Cat. # 178479) was purchased from 
Calbiochem (San Diego, CA). The HRP conjugated secondary antibody, rabbit anti-goat 
IgG (Cat.# AP106P) was obtained from Chemicon (Temecula, CA). All other materials 
used for apoE quantitation, including pre-cast 4-20% gradient gel (Cat. # FB3435), 
Millipore Immobilon-P Transfer Membrane (Cat. # IPVHOOOlO), Pierce SuperSignal 
West Pico Chemiluminescent Substrate (Cat.# PI34080), Kodak BioMax Light-2 film (5 
x 7', Cat. # 05-728-53), Tris (Cat. # BP154-l), Glycine (Cat. # BP381-1), SDS (Cat. # 
BP166-100), Tween 20 (Cat. # BP337-500) and sodium bromophenol blue (Cat. # 
BPI 14-25) were purchased from Fisher Scientific (Chicago, IL). 
Immunocytochemistry: The mouse anti-neurofilament-200 (Cat. # N-5389), rabbit anti-
galactocerebroside (Cat. # N-9152), and mouse anti-Glial Fibrillary Acidic Protein 
(GFAP) (Cat. # N-3893) were obtained from Sigma Chemicals (St. Louis, MO). The 
FITC-conjugated goat anti-mouse IgG-Fab2 specific (Cat. # 115-095-006), FITC-
conjugated AffiniPure goat anti-rabbit IgG (H+L) (Cat. # 111-095-144), Cy3 conjugated 
AffiniPure goat anti-mouse IgG (H+L) (Cat.# 111-165-146) and normal goat serum (Cat 
# 005-000-121) were purchased from Jackson ImmunoResearch (West Grove, PA). 
Paraformaldehyde (Cat. # 04042-500) was purchased from Fisher Scientific (Chicago, 
IL). Triton X-100 (Cat. # T-9284), n-Propyl gallate (Cat. # P-3130), and glycerol (Cat. # 
G-6279) were purchased from Sigma Chemicals (St. Louis, MO). 
Methods: 
Culture of AMC Neurons: For each experiment, a single male, 4 month old homozygous 
apoE KO or C57BL6/J mouse was anesthetized with sodium pentobarbital (80 mg/kg). 
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The entire cerebral cortex was dissected from the brain in 2 ml B27 /HibernateA medium 
[B27/HibernateA with 0.5 mM glutamine] in a 35 mm diameter petridish at 4 °C. The 
cortex was sliced (0.5 mm) and transferred to a 50 ml tube containing 5 ml 
B27/HibernateA medium. After warming for 8 min at 30 °C, slices were digested with 6 
ml of a 2 mg/ml papain solution in HibernateA for 30 min at 30 °C in a gyrating water 
bath to keep the slices suspended. Slices were transferred to 2 ml B27 /HibernateA 
medium in a 15 ml tube. After 2 min at room temperature, slices were triturated 10 times 
with a siliconized 9-inch Pasteur pipette, and allowed to settle for 1 min. Approximately 
2 ml of the supernatant was transferred to another tube, and the sediment was 
resuspended in 2 ml B27/HibernateA medium. The above step was repeated twice, and a 
total of 6 ml was collected. The resultant supernatant was subjected to density gradient 
centrifugation at 800 X g for 15 min. The Optiprep gradient was prepared in four 1 ml 
steps of 35, 25, 20 and 15% Optiprep in B27/HibernateA medium (v/v). The fraction 
containing the neurons was collected, and diluted in 5 ml B27 /HibernateA medium. 
After centrifuging twice at 200 X g for 2 min, the cell pellets were resuspended in 3 ml 
B27/Neurobasal medium [B27/Neurobasal with 0.5 mM glutamine, no glutamate, 0.01 
mg/ml gentamicin]. The cells in the suspension were counted in a hemacytometer, and 
plated in 40 to 50 µl aliquots on glass coverslips previously coated with 50 µg/ml poly-
D-lysine in water. Coverslips were coated the night before the cell culture with 100 µl 
poly-D-lysine solution on each coverslip. On the day of the culture, coverslips were 
rinsed with distilled water and allowed to air-dry. Following lh incubation in a 
0 
humidified incubator at 37 Cand 5% C02, coverslips were transferred to a 24-well plate 
containing 0.4 ml B27/NeurobasalA medium. Coverslips were rinsed twice with 
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B27/HibernateA medium, and then 0.4 ml growth medium [B27/Neurobasal medium 
with 5 ng/ml FGF2] was added to each well and the plate was further incubated. After 4 
days of incubation, neurite outgrowth was assessed as described below. For cultures 
longer than 4 days, half of the medium was replaced with B27 /Neurobasal with 10 ng/ml 
FGF2 every four days. 
Neurite Outgrowth: To assess neurite outgrowth, AMC cells were grown in growth 
medium (GM) alone or with other test reagents (human-apoE, inhibitors, etc.). Following 
4 days of incubation, the length of the longest neurite (neurite extension) and total length 
of neurites (combined length) of each neuron were measured by using an inverted phase-
contrast microscope. For each experiment, a minimum of 40 to 50 neurons were 
measured for each treatment condition. All experiments were repeated four times using 
different preparations of AMC neurons, and reagents. The data in individual experiments 
were presented as the mean± standard error, and analyzed by an independent t-tests (a.= 
0.05). 
In experiments that involved the effects of human apoE on neurite outgrowth, AMC 
cultures from apoE KO mice were prepared as previously described. After 24 hrs 
incubation, various concentrations of recombinant human apoE3 and recombinant human 
apoE4 were added directly to the medium. Commercial recombinant human apoE was 
purchased from Panvera and was dissolved in 0.7 M NH4HC03. Before adding to the 
culture, apoE was dialyzed in 0.1 M NH4HC03 overnight. On the fourth day of culture, 
neurite outgrowth was quantified. 
In studies on the effects of inhibitors of lipoprotein receptors, AMC neurons from 
apoE KO mice were incubated for 24 hrs in growth medium prior to the addition of RAP 
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(5 µg/ml), or lactoferrin (10 µg/ml) to the medium. After one hour, recombinant human 
apoE3 (2.5 µg/ml) or recombinant human apoE4 (2.5 µg/ml) was added. The inhibitors 
were re-added to the medium every 24 hrs, assuming that the previously added inhibitors 
were totally consumed; following a 4-day incubation period, neurite outgrowth was 
assayed. 
Medium Swapping Experiment: An AMC neuronal culture from control mice was 
prepared as described above. After a 24-hr period, AMC culture from apoE KO mice 
was prepared. After a 1-hr incubation, the culture medium from the apoE KO culture 
was removed and the cells were rinsed with B27 /HibernateA medium. Conditioned 
medium from control cultures that were 24 hrs old, was centrifuged to remove suspended 
cells and cellular debris, was added to the KO culture. Every 24 hrs, the KO culture 
medium was replaced with medium from the control culture. On the fourth day of each 
culture, the neurite outgrowth was assayed. 
ApoE Quantification: Medium from four-day-old control mice cultures was collected and 
centrifuged to eliminate suspended cells. ApoE was immunoprecipated by incubating the 
medium with 0.8 µg mouse anti-human apoE on ice for 1 hr. Following incubation, 50 µl 
of 10% Protein A-Sepharose CL-48 was added, and the medium was further incubated 
on ice for 1 hr on a shaker. The medium was centrifuged at 10,000 X g for 15 min at 4 
°C, and the supernatant discarded. The pellet was boiled for 5 min in 2X Lammeli 
sample buffer (6.25 ml 4X Tris/SDS [pH 6.8], 5 ml glycerol, lg SDS, 0.5 ml 2-
mercaptoethanol, bromophenol, 13.25 ml dH20) and electrophoresed on 4-20% 
polyacrylamide gradient gels in an EC 120 Mini gel vertical system. The samples were 
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run at 80 volts until separation began, and then at 140 volts until the dye front reached 
near the bottom of the gel. (Bellosta et al., 1995). 
Following electrophoresis, the gel was placed in transfer buffer (3.03 g Tris-base, 14.4 
g glycine, 200 ml methanol, 800 ml dH20) on a shaker for 10 min. The transfer 
membrane, Millipore Immobilon-P Transfer Membrane, was first soaked in methanol for 
5 sec and then washed in dH20 for 5 min to remove excess methanol. The gel was 
placed on a presoaked filter paper in the holder and the transfer membrane was placed on 
top of the gel. The gel holder was placed in the buffer tank of Trans-blot Transfer Cell 
and the entire chamber was filled with transfer buffer. Proteins from the gel were 
transferred onto the membrane by passing 100 volts for an hour. 
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After transferring, blots were blocked in TBS buffer [20 mM Tris-HCl, 150 mM 
NaCl, pH 7.5] with 1 % BSA at 4 °C overnight or at room temperature for 1 hr. Then 
blots were washed twice, 5 min each, with TBST buffer [TBS buffer with 0.05% Tween 
20]. Blots were then incubated in goat anti-human apoE (1 :5,000 dilution in TBST 
buffer) for 1 hr on a shaker at room temperature. The membrane was then washed 4 
times, 10 minutes each, in TBST buffer. Blots were incubated in HRP conjugated rabbit 
anti-goat IgG (1:10,000 dilution in TBST buffer) for 1 hr on a shaker at room temp, 
washed 5 times, 10 min each, with TBST buffer, incubated with Pierce SuperSignal West 
Pico Chemiluminescent Substrate, and then exposed to Kodak BioMax Light-2 film. A 
35 kDa band was visualized which is consistent with the published molecular weight of 
apoE. 
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All experiments were repeated at least three times to assure the reproducibility of the 
results. Bands were quantified by densitometry (Scion Image). Statistical analysis 
(unpaired, two tailed t-test) was performed by using Statview software. 
Immunocytochemistry 
a) Neurons: After four days of incubation, cells were rinsed with warm PBS (37 °C) and 
then fixed with 4% paraformaldehyde in PBS for 20 min at room temperature. After 
rinsing twice with PBS, cells were permeabilized with 0.5% Triton X-100 in PBS for 5 
min. Cells were rinsed again with PBS, and then blocked with blocking solution [5% 
normal goat serum, 0.5% Triton X-100 in PBS] for 5 min. Cells were incubated 
overnight at 4 °C with mouse anti-neurofilament 200 (diluted 1:40) in the blocking 
solution. After rinsing four times with PBS, cells were incubated with FITC-conjugated 
goat anti-mouse IgG-Fab2 (diluted I :200) in blocking solution at room temperature for 1 
hr. Cells were washed four times in PBS, and the coverslips were mounted on glass 
slides in anti-photobleach [0.04g n-Propyl gallate, 6 ml glycerol, I ml lOxTBS, pH7.4, 
and bring the volume to I 0 ml with dH20]. 
b) Oligodendrocytes: After a four day incubation period, cells were rinsed with warm 
PBS (37 °C) and then fixed with 4% paraformaldehyde in PBS for 20 min at room 
temperature. After rinsing twice with PBS, cells were blocked with blocking solution 
[1% normal goat serum, 1% BSA in PBS] for 5 min. Cells were then incubated at room 
temperature for I hr with rabbit anti-galactocerebroside (diluted 1:50) in the blocking 
solution, rinsed four times with PBS, and incubated with FITC-conjugated AffiniPure 
goat anti-rabbit lgG (H+L) (diluted I :200) in blocking solution at room temperature for 1 
14 
hr. Cells were then washed four times in PBS, and the coverslips were mounted on glass 
slides in anti-photobleach. 
c) Astrocytes: After four days of incubation, cells were rinsed with warm PBS (37 °C) 
and fixed with 4% paraformaldehyde in PBS for 10 min at room temperature. After 
rinsing twice with PBS, cells were blocked with blocking solution [5% normal goat 
serum, 0.05% Triton X-100 in PBS] for 5 min, and incubated at room temperature for 1 
hr or 4 °C overnight with mouse monoclonal anti-Glial Fibrillary Acidic Protein (GF AP) 
(diluted 1: 1200) in the blocking solution. After rinsing four times with PBS, cells were 
incubated with Cy3 conjugated AffiniPure goat anti-mouse IgG (H+L) (diluted 1 :3000) 
in blocking solution at room temperature for 1 hr, then washed four times in PBS, and the 
coverslips were mounted on glass slides in anti-photobleach. 
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Results: 
Characterization of AMC neuronal culture: As a first step towards studying the effects of 
apoE on adult neurons, I developed techniques for culturing adult mice neurons. The 
average total number of viable cells recovered from three preparations after 4 days in 
culture was 60.7 ± 3.3% (mean± S.D.). Cell types in the culture were determined by 
immunofluorescent labeling of specific cell type markers; markers used are neurofilament 
200 for neurons, galactocerebroside for oligodendrocytes, and GF AP for astrocytes. The 
majority of cells in the culture were neurofilament positive, representing - 70% of the 
cells. About 14% of the cells were stained with galactocerebroside. GFAP positive cells 
were present at low levels with an average of 13%. 
The levels of apoE secreted into the medium by cells in the AMC culture was 
assessed by immunoblotting technique and quantitated by densitometry. The cells 
secreted 10.64 ± 0.62 ng/ml of apoE in 96 hrs. 
Effects of deficiency of mouse apoE expression on neurite outgrowth: To evaluate 
whether lack of mouse apoE expression affects neurite outgrowth, I compared neurite 
extension and combined length of neurites in cultures of AMC neurons from apoE KO 
mice with cultures derived from the same age, sex, and strain matched wild-type mice. 
Neurite outgrowth was monitored at 96 hrs. AMC neurons from apoE KO mice had 
significantly shorter (p<O. 01) neurite extension and combined length as compared with 
those in neurons from wild-type mice (Fig. 1 & 2). To directly test if the attenuated 
neurite outgrowth observed in apoE KO culture is due to the absence of apoE expression, 
I incubated the apoE KO neurons with conditioned medium from wild-type mice. Neurite 
outgrowth from apoE KO mice grown in conditioned medium from wild-type mice was 
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Figure 1. Effects of deficiency of mouse apoE expression on neurite extension of adult 
mice cortical neurons (mean± pooled S.E., a < 0.05). The AMC neurons from apoE KO 
mice had significantly shorter (p<0.01) neurite outgrowth as compared to control mice. 
There was no significant difference between apoE KO culture incubated with conditioned 
medium and control culture regarding to neurite extension. 
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Figure 2. Effects of deficiency of mouse apoE expression on combined length of adult 
mice cortical neurons (mean ± pooled S.E., a < 0.05). The combined length of the 
neurites of AMC neurons from KO mice was significantly less (p<0.01) than that in 
AMC neurons from control mice. In the presence of the control medium, the combined 
length of KO culture was similar to that of control culture. 
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essentially similar to those in neurons from wild-type culture (Fig. 1 & 2). These data 
show that absence of apoE expression inhibits neurite outgrowth from AMC neurons. 
Differential effects of human apoE3 and human apoE4 on neurite outgrowth: To 
determine whether human apoE isoforms affect neurite outgrowth from adult neurons, 
AMC culture from apoE KO mice were incubated in medium alone or in medium 
containing recombinant human apoE3 or human apoE4. Four days after treatment, 
neurons were scored for neurite outgrowth. Incubation of AMC culture with apoE3 
significantly (p<0.01) increased both neurite extension and combined length (Fig. 3 & 4). 
In contrast to apoE3, addition of human apoE4 to the medium decreased (p<0.01) both 
neurite extension and combined length (Fig. 3 & 4), essentially stunting neurite 
outgrowth. These observations were confirmed when neurite outgrowth was quantified. 
Treatment of culture with apoE3 increased extension and combined length of neurites, 
whereas apoE4 significantly decreased both neurite extension and combined length. It is 
important to note that, addition of as little as 1 µg/ml of apoE4 increased neurite 
outgrowth from AMC neurons. 
LRP pathway mediates the differential effects of apoE isoforms on neurite outgrowth: In 
previous studies our laboratory has shown that the effects of apoE on neurite growth are 
mediated by lipoprotein receptors. To determine which receptor was involved in 
mediating the differential effects of apoE3 and apoE4 on neurite outgrowth, I used 
inhibitors, lactoferrin and RAP to block the binding and internalization of apoE-
containing lipoproteins by the LRP pathway. Both lactoferrin and RAP have been 
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Figure 3. Differential effects of human apoE3 and human apoE4 on neurite extension of 
adult mice cortical neurons (mean ± pooled S.E., a < 0.05). Incubation of AMC KO 
culture with apoE3, significantly increased (p<0.01) neurite extension in a dose 
dependent fashion. Incubation of cells with apoE4 decreased (p<0.01) neurite extension 
in a dose dependent fashion. 
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Figure 4. Differential effects of human apoE3 and human apoE4 on combined length of 
adult mice cortical neurons (mean ± pooled S.E., a. < 0.05). Incubation of AMC KO 
culture with apoE3, significantly increased (p<0.01) combined length in a dose dependent 
fashion while incubation of cells with apoE4 decreased (p<0.01) combined length in a 
dose dependent fashion. 
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previously shown to abolish the binding of apoE-enriched lipoproteins to the LRP. As 
shown in Fig. 5 & 6, treatment of AMC culture with lactoferrin and RAP blocked the 
differential effects of the apoE isoforms on neurite outgrowth. In the presence of 
lactoferrin and RAP the stimulatory effects of apoE3, and the inhibitory effect of apoE4 
were abolished, and both neurite extension and combined length of neurites from apoE-
treated AMC neurons were similar to those observed in neurons grown in medium alone. 
These data show that inhibition of the interaction of apoE with the LRP prevents the 
isoform specific effects of human apoE on neurite outgrowth. 
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Figure 5. LRP pathway mediates the differential effects of apoE isoforms on neurite 
extension of adult mice cortical neurons (mean± pooled S.E., a. < 0.05). In the presence 
of either lactoferrin or RAP, the stimulatory effect of apoE3, and the inhibitory effect of 
apoE4 were abolished, and neurite extension of apoE-treated KO neurons were similar to 
those observed in neurons grown in medium alone. 
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Figure 6. LRP pathway mediates the differential effects of apoE isoforms on combined 
length of adult mice cortical neurons (mean± pooled S.E., a < 0.05). In the presence of 
either lactoferrin or RAP, the stimulatory effect of apoE3, and the inhibitory effect of 
apoE4 were abolished, and combined length of apoE-treated KO neurons were similar to 
those observed in neurons grown in medium alone. 
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Discussion: 
Because of observations made over the past several years, the role of apoE in central 
nervous system (CNS) has drawn a lot of attention from researchers. ApoE messenger 
RNA has been found to be abundant in the brain and primarily synthesized and secreted 
by astrocytes and microglia macrophages {Elshourbagy et al., 1985; Pitas et al., 1987a). 
ApoE-containing lipoproteins are found in the cerebrospinal fluid and appear to play a 
major role in lipid transport in the CNS. It has also been found that apoE levels increase 
dramatically after peripheral nerve injury. Recently, apoE4 has been implicated to be 
associated with sporadic and late-onset familial AD (Poirier et al., 1993; Beffert et al., 
1998). Numerous studies are now focusing on the mechanism whereby apoE leads to the 
pathogenesis of AD. One possible mechanism of apoE involvement in AD may be on 
processes involved in neurite development, given the well-known role of apoE in lipid 
transport. Several previous studies have demonstrated an isoform-specific effect of apoE 
on neurite outgrowth from both central nervous system- (Neuro-2a cells and GTl trk 9 
cells) and peripheral nervous system- (dorsal root ganglion cells) derived neurons 
(Nathan et al., 1994; Bellosta et al., 1995; Holtzman et al., 1995; Nathan et al., 1995). In 
the presence of lipoprotein, apoE3 enhances neurite outgrowth, whereas apoE4 inhibits 
neurite outgrowth. Although these studies have provided useful information, the 
relevance of these findings to adult neurons and AD is still not known. 
The animal model used in this study, apoE KO mice, provides a unique opportunity to 
study the role of apoE in the CNS. In apoE KO mice, part of the apoE gene is replaced 
by a neomycin-resistance gene; this insertion disrupts the structure and function of apoE 
(Piedrahita et al., 1992). ApoE KO mice have significant retardation in the acquisition of 
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developmental milestones, (forelimb placing behavior and cliff avoidance behavior) 
learning and memory impairments (Gazes et al., 1997; Zhou et al., 1998; Krzywkowski 
et al., 1999), and altered stress responsiveness (Zhou et al., 1998). It has also been found 
that apoE-deficient mice exhibit an impaired ability to recover from closed head injuries 
(Chen et al., 1997). ApoE-deficient mice treated with either apoE3 or apoE4 show a 
significant improvement in their learning capacity in the Morris water maze compared to 
saline-infused apoE KO mice (Masliah et al., 1997). Because apoE is a ligand for 
receptors that clear remnants of chylomicrons and VLDL, lack of apoE causes a high 
plasma cholesterol (5 fold) and severe occlusion of the coronary artery ostium in apoE-
deficient mice (Zhang et al., 1992). 
Taken together, the apoE KO mouse system is an excellent model to study the role of 
apoE in the CNS and may shed light on the relationship between apoE and AD. By using 
this model, I have demonstrated that apoE isoforms exert differential effects on neurite 
outgrowth from adult mice cortical neurons. Incubation of AMC neurons with apoE3 
increased both neurite extension and combined neurite length, whereas incubation with 
apoE4 decreased both extension and combined length, essentially stunting outgrowth. 
Furthermore, this study clearly demonstrates that the effects of apoE on neurite 
outgrowth are mediated via the LRP. 
My studies provide evidence that nanogram quantities of endogenously produced 
mouse apoE facilitates neurite outgrowth. AMC neurons from apoE KO mice had 
significantly shorter neurite extensions and combined length of neurites as compared to 
those in AMC neurons from control mice. The decreased neurite outgrowth observed in 
apoE KO culture is not due to the property of the neurons, but is a result of the absence of 
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apoE production. The neurite outgrowth from apoE KO mice grown m conditioned 
medium from wild-type mice was essentially similar to those in neurons from wild-type 
culture. These results are consistent with other studies that showed impaired nerve 
recovery in apoE KO mice. Thus, endogenously secreted mouse apoE facilitates neurite 
outgrowth similar to human apoE3, even though mouse apoE is similar to human apoE4 
in having arginine at positions 112 and 158. However, previous structural and functional 
studies on apoE have revealed that mouse apoE is "apoE3-like" because of the lack of 
arginine at position 61 which determines many of the isoform specific properties of 
apoE3 and apoE4, including the lipoprotein preferences. 
I have demonstrated that the differential effects of apoE isoforms on neurite outgrowth 
seen in embryonic and neuronal cell lines also is observed in neurons derived from the 
adult brain. As little as 1 µg/ml recombinant human apoE3 present in KO culture can 
increase neurite extension. Addition of 5 µg/ml human apoE3 increased the length of the 
longest neurite by 25% and the combined length by 30% while the same amount of 
human apoE4 decreased the length of the longest neurite by almost 30% and the 
combined length by 35%. In previous studies (Nathan et al., 1994; Bellosta et al., 1995; 
Holtzman et al., 1995; Nathan et al., 1995), addition of a lipid source to the culture 
medium is required to elicit the differential effects of apoE3 and apoE4 on neurite 
outgrowth. In the AMC culture, however, purified apoE alone, in the absence of 
exogenous sources of lipid, led to the differential effects of apoE3 and apoE4 on neurite 
outgrowth. These results are not inconsistent since AMC culture is only a partially 
purified preparation and therefore contains cellular debris that could have served as a 
lipid source. In fact, a previous study (Nathan et al., 1994) has shown that purified rabbit 
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apoE, in the absence of a source of lipid, reduced neurite outgrowth from a partially 
purified preparation of rabbit DRG neuron. 
In previous studies it has been shown that the isoform-specific effects of apoE3 and 
apoE4 on neurite outgrowth appeared to require the interaction of apoE-containing 
lipoproteins with the LRP (Holtzman et al., 1995). The role of the HSPG in the process 
is to sequester apoE-enriched lipoproteins. Consistent with these previous findings, my 
data also suggest that the LRP/HSPG pathway is important for the differential effects of 
apoE3 and apoE4 on neurite outgrowth in AMC neurons. In the presence of lactoferrin 
(lactoferin blocks the binding of lipoprotein to both HSPG and the LRP) or RAP, the 
differential effects on neurite outgrowth caused by apoE3 and apoE4 in the KO AMC 
culture were abolished. 
The precise mechanism by which apoE leads to the development of AD is unclear. 
However, based on my results, I have developed a model that might help to explain the 
potential role of apoE in the pathogenesis of AD. The model proposes that AD is an 
imbalance between neuronal injury and efficient repair. In this model, neurons that are 
debilitated by age are more susceptible to neurotoxic agents (e.g., amyloid peptide, free 
radicals). The damage inflicted by these injurious agents signal the need for repair or 
remodeling of the neurons and neurites. At this stage, apoE3 in the brain may support the 
repair process, whereas apoE4 being produced in the aging brain would not support repair 
mechanism. Thus apoE4 would serve as a susceptibility factor for the development of 
neurodegenerative diseases like Alzheimer's disease. 
28 
References: 
Battey, F.D., Gafvels, M.E., FitzGerald, D.J., Argraves, S.W., Chappell, D.A., Strauss, 
J.F. III and Strickland D.K. (1994). The 39-kDa receptor-associated protein 
regulates ligand binding by the very low density lipoprotein receptors. J. Biol. 
Chem. 269, 23268-23273. 
Beffert, U., Danik M., Krzywkowski, P., Ramassamy, C., Berrada, F., and Poirier, J. 
(1998). The neurobiology of apolipoproteins and their receptors in the CNS and 
Alzheimer's disease. Brain Research Reviews. 27, 119-142. 
Bellosta, S., Nathan, B.P., Orth, M., Dong, L.-M., Mahley, R.W. and Pitas, RE. (1995). 
Stable expression and secretion of apolipoprotein E3 and E4 in mouse 
neuroblastoma cells produces differential effects on neurite outgrowth. J. Biol. 
Chem. 270,27063-27071. 
Bradley, W.A., Hwang, S.-L.C., Karlin, J.B., Lin, A.HY., Prasas, D.C., Gotto, AM., Jr., 
and Gianturco, S.H. (1984). Low-density lipoprotein receptor binding 
determinants switch from apolipoprotein E to apolipoprotein B during conversion 
of hypertriglyceridemic very-low-density lipoprotein to low-density lipoprotein. 
J. Biol. Chem. 259, 14728-14735. 
Chen, Y., Lomnotski, L., Michaelson, D.M. and Shohami, E. (1997). Motor and cognitive 
deficits in apolipoprotein E-deficient mice after closed head injury. Neuroscience 
80, 1255-1262. 
Corder, E.H., Saunders, AM., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, 
G.W., Roses AD., Haines, J.L. and Pericak-Vance, M.A. {1993). Gene dose of 
29 
apolipoprotein E type 4 allele and the risk of Alzheimer's disease in the late onset 
families. Science 261, 921-923. 
Das, H.K., McPherson, J., Bruns, G.A.P., Karathanasis, S.K., and Breslow, J.K. (1985). 
Isolation, characterization, and mapping to chromosome 19 of the human 
apolipoprotein E gene. J. Biol. Chem. 260, 6240-6247. 
Elshourbagy, N.A., Liao, W.S., Mahley, R.W., and Taylor, J.M. (1985). Apoliprotein E 
mRNA is abudant in the brain and adrenals, as well as in the liver, and is present 
in other peripheral tissues of rats and marmosets. Proc. Natl. Acad Sci. U.S.A. 82, 
203-207. 
Gooch, M.D. and Stennett, DJ. (1996). Molecular basis of Alzheimer's disease. Am. J. 
Health-Syst. Pharm. 53, 1545-1604. 
Gozes, I., Bachar, M., Bardea, A., Davidson, A., Rubinraut, S., Fridkin, M. and Giladi, E. 
( 1997). Protection against development retardation in apolipoprotein E-deficient 
mice by a fatty neuropeptide: implications for early treatment of Alzheimer's 
disease. J. Neurobiol. 33, 329-342. 
Herz, J., Hamann, U., Rogne, S., Myklebost, 0., Gausepohl, H. & Stanley, K. K. {1988) 
Surface location and high affinity for calcium of a 500-kd liver membrane protein 
closely related to the LDL-receptor suggest a physiological role as lipoprotein 
receptor. Embo. J. 7, 4119-4127. 
Haass, C. and Selkoe, D.J. (1993). Cellular processing of beta-amyloid precursor protein 
and the genesis of amyloid beta-peptide. Cell, 75, 1039-1042. 
Holtzman, D.M., Pitas, RE., Kilbridge, J., Nathan, B.P., Mahley, R.W., Bu, G. and 
Schwartz, AL. (1995). Low density lipoprotein receptor-related protein mediates 
30 
apolipoprotein £-dependent neurite outgrowth in a central nervous system-derived 
neuronal cell line. Proc. Natl. Acad Sci. U.S.A. 92, 9480-9484. 
Ignatius, M.J., Gebicke-Harter, P.J., Skene, J.H., Schilling, J.W., Weisgraber, K.H., 
Mahley, R. W. and Shooter, E.M. (1986). Expression of apolipoprotein E during 
nerve degeneration and regeneration. Proc. Natl. Acad Sci. U.S.A. 83, 1125-1129. 
Ignatius, M.J., Shooter, E.M., Pitas, RE. and Mahley, R.W. (1987). Lipoprotein uptake 
by neuronal growth cones in vitro. Science, 236, 959-962. 
Ji, Z.-S., Brecht, W.J., Miranda, D.R., Hussain, M.M., Innerarity, T.L. and Mahley, R.W. 
(1993). Role of heparan sulfate proteoglycans in the binding and uptake of 
apolipoprotein £-enriched remnant lipoprotein by cultured cells. J. Biol. Chem. 
268, 10160-10167. 
Ji, Z.-S. and Mahley, R.W. (1994). Lactoferrin binding to heparan sulfate proteoglycans 
and the LDL receptor-related protein, further evidence supporting the importance 
of direct binding of remnant lipoproteins to HSPG. Arteriosclerosis and 
Thrombosis 14, 2025-2031. 
Kowel, R.C., Herz, J., Goldstein, J.L., Esser, V. and Brown M.S. (1989). Low density 
lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived 
from apoprotein £-enriched lipoproteins. Proc. Natl. Acad. Sci. U.S.A. 86, 5810-
5814. 
Kowel, RC., Herz, J., Weisgraber, K.H., Mahley, R.W., Brown. M.S. And Goldstein J.L. 
(1990). Opposing effects of apolipoprotein E and C on lipoprotein binding to low 
density lipoprotein receptor-related protein. J. Biol. Chem. 265, 10771-10779. 
31 
Krzywkowski, P., Ghribi, 0., Gagne, J., Chabot, C., Kar, S., Rochford, J., Massicotte, G., 
Poirier, J. Cholinergic systems and long-term potentiation in memory impaired 
apolipoprotein E deficient mice. Neuroscience, 92, 1273-1286 
Mahley, R. W. (1988). Apolipoprotein E: cholesterol transport protein with expanding 
role in cell biology. Science. 240, 622-629. 
Mahley, R.W., Ji, Z.-S., Brecht, W.J., Miranda, D.R. and He, D.-P. (1994). Role of 
heparan sulfate proteoglycans and the LDL receptor-related protein in remnant 
lipoprotein metabolism. Ann. N. Y. Acad Sci. 737, 39-52. 
Mahley, R.W., Nathan, B.P., and Pitas, RE. (1995). Apolipoprotein E Structure, 
function, and possible roles in Alzheimer's Disease. Ann. N. Y. Acad Sci. 777, 
139-145. 
Masliah, E., Samuel, W., Veinbergs, I., Mallory, M., Mante, M. and Saitoh, T. (1997). 
Neurodegeneration and cognitive impairment in apoE-deficient mice ts 
ameliorated by infusion of recombinant apoE. Brain Res. 751, 307-314. 
Metz-Boutigue, M-H., Jolles, J., Mazurier, J., Schoentgen, F., Legrand, D., Spik, G., 
Montreuil, J. and Jolles, P. (1984). Human lactotransferrin: amino acid sequence 
and structureal comparisons with other transferrins. Eur. J. Biochem. 145, 659-
676. 
Nathan, B.P., Bellosta, S., Sanan, D.A., Weisgraber, K.H., Mahley, R.W. and Pitas, RE. 
(1994). Differential effects of apolipoproteins E3 and E4 on neuronal growth in 
vitro. Science 264, 850-852. 
32 
Nathan, B.P., Chang, K.-C., Bellosta, S., Brisch, E., Ge, N., Mahley, R.W. and Pitas, RE. 
(1995). The inhibitory effect of apolipoprotein E4 on neurite outgrowth is 
associated with microtubule depolymerization. J. Biol. Chem. 270, 19791-19799. 
Paik, Y.-K., Chang, D.J., Reardon, C.A., Davis, G.E., Mahley, R.W., and Taylor, J. M. 
(1985). Nucleotide sequence and structure of the human apolipoprotein E gene. 
Proc. Natl. Acad Sci. US.A. 82, 3445-3449. 
Piedrahita, J.A., Zhang, S.H., Hagaman, J.R., Oliver, P.M. and Maeda, N. (1992). 
Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene 
targeting in embryonic stem cells. Proc. Natl. Acad Sci. US.A. 89, 4471-4475. 
Pitas, RE., Boyles, J.K., Lee, S.H., Foss, D. and Mahley, RW. (1987a). Astrocytes 
synthesize apolipoprotein E and metabolize apolipoprotein £-containing 
lipoproteins. Biochem. Biophys. Acta. 917, 148-161. 
Pitas, RE., Boyles, J.K, Lee, S.H., Hui, D.Y. and Weisgraber, K.H. (1987b). 
Lipoproteins and their receptors in the central nervous system: Characterization of 
the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E 
(LDL) receptors in the brain. J. Biol. Chem. 262: 14352-14360. 
Poirier, J., Hess, M., May, P.C., and Finch, C.E. (1991). Astrocytic apolipoprotein E 
mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesion. Mal. 
Brain Res. 11, 97-106. 
Poirier, J., Davignon, J., Bouthillier, D., Kogan, S., Bertrand, P., and Gauthier, S. (1993). 
Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 342, 697-699. 
Poirier, J. (1994). Apolipoprotein E in animal models of CNS injury and in Alzheimer's 
disease. Trends Neurosci. 17, 525-530. 
33 
Rall, S.C., Jr., Weisgraber, K.H., and Mahley, R.W. (1982). Human Apolipoprotein E 
The complete amino acid sequence. J. Biol. Chem. 257, 4171-4178. 
Takahashi, S., Kawarabayasi, Y., Nakai, T., Sakai, J. & Yamamoto, T. (1992) Rabbit 
very low density lipoprotein receptor: a low density lipoprotein receptor-like 
protein with distinct ligand specificity. Proc. Natl. Acad Sci. U. S. A. 89, 9252-
9256. 
Vassar, R., Bennett, B.D., Babu-Khan, S., Kahn, S., Mendiaz, E.A., Denis, P., Teplow, 
D.B., Ross, S., Amarante, P., Leoloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, 
S., Lile, J., Jarosinski, M.A., Biere, A. L., Curran, E., Burgess, T., Louis J, -C., 
Collins. F., Treanor, J., Rogers, G., and Citron, M. (1999). ~-Secretase cleavage 
of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease 
BACE. Science. 286, 735-741. 
Weisgraber, K.H. (1994). Apolipoprotein E: Structure-Function. Adv. Protein Chem. 45, 
249-302. 
Williams, S.E., Ashcom, J.D., Argraves, S.W. and Strickland, D.K. (1992). A novel 
mechanism for controlling the activity of a 2-macroglobulin receptor/low density 
lipoprotein receptor-related protein. Mutiple regulatory sites for 39-kDa receptor-
associated protein. J. Biol. Chem. 267, 9035-9040. 
Willnow, T. E., Goldstein, J. L., Orth, K., Brown, M. S. & Herz, J. (1992) Low density 
lipoprotein receptor-related protein and gp330 bind similar ligands, including 
plasminogen inhibitor complexes and lactoferrin, an inhibitor of chylomicron 
remnant clearance. J. Biol. Chem. 267, 26172-80. 
34 
Zhang, S.H., Reddick, R.L., Piedrahita, J.A. and Maeda, N. (1992). Spontaneous 
hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. 
Science 258, 468-4 71. 
Zhou, Y., Elkins, P.D., Howell, L.A. Ryan, D.H. and Harris, R.B. (1998). 
Apolipoprotein-E dificiency results in an altered stress responsiveness in addition 
to an impaired spatial memory in your mice. Brain Res. 788, 151-159. 
35 
